Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2024 | 03-2023 | 03-2022 | 03-2021 | 03-2020 | |
| Sales | 56,625 | 34,155 | 32,262 | 25,381 | 17,995 |
| Cost of Goods | 30,268 | 17,561 | 17,467 | 13,514 | 10,016 |
| Gross Profit | 26,357 | 16,594 | 14,795 | 11,867 | 7,979 |
| Operating Expenses | 15,836 | 13,479 | 10,191 | 10,276 | 10,280 |
| Operating Income | 10,789 | 3,676 | 5,071 | 2,105 | -2,285 |
| Interest Expense | 589 | 1,113 | 192 | 260 | 356 |
| Other Income | -9,737 | 1,423 | 1,426 | 2,300 | 403 |
| Pre-tax Income | 463 | 3,986 | 6,304 | 4,145 | -2,238 |
| Income Tax | -19,646 | 424 | -1,736 | N/A | 2 |
| Net Income Continuous | 20,109 | 3,562 | 8,898 | 5,088 | -2,240 |
| Net Income | $20,109 | $3,562 | $8,898 | $5,088 | $-2,240 |
| EPS Basic Total Ops | 0.02 | 0.00 | 0.01 | 0.01 | 0.00 |
| EPS Basic Continuous Ops | 0.02 | 0.00 | 0.01 | 0.01 | 0.00 |
| EPS Diluted Total Ops | 0.02 | 0.00 | 0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.02 | 0.00 | 0.01 | 0.01 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 0.03 | 0.00 | 0.01 | 0.01 | 0.00 |
| EBITDA(a) | $12,260 | $5,021 | $6,505 | $3,629 | $-775 |